TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 17

1.2 MARKET ATTRACTIVENESS ANALYSIS 18

1.3 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY SOFTWARE TYPE 18

1.4 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY MODE OF DEPLOYMENT 19

1.5 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET BY APPLICATION 20

1.6 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY END USER 21

2 MARKET INTRODUCTION
2.1 DEFINITION 22

2.2 SCOPE OF THE STUDY 22

2.3 RESEARCH OBJECTIVE 22

2.4 MARKET STRUCTURE 22

2.5 ASSUMPTIONS & LIMITATIONS 23

3 RESEARCH METHODOLOGY
3.1 DATA MINING 24

3.2 SECONDARY RESEARCH 25

3.3 PRIMARY RESEARCH 26

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 27

3.5 FORECASTING TECHNIQUES 28

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 29

3.6.1 BOTTOM-UP APPROACH 30

3.6.2 TOP-DOWN APPROACH 30

3.7 DATA TRIANGULATION 31

3.8 VALIDATION 31

4 MARKET DYNAMICS
4.1 OVERVIEW 32

4.2 DRIVERS 33

4.2.1 INCREASING VOLUME OF UNSTRUCTURED DATA IN THE HEALTHCARE INDUSTRY 33

4.2.2 IMPLEMENTATION OF ‘HL7 QRDA-III STU RELEASE2.1' GUIDELINES & ICD 10 33

4.2.3 RISE IN MEDICAL ERRORS 33

4.2.4 INCREASING GOVERNMENT INITIATIVES BY PUBLIC AND PRIVATE ORGANIZATIONS 33

4.3 RESTRAINTS 34

4.3.1 DATA SECURITY CONCERNS 34

4.3.2 UNWILLINGNESS TO DEVELOP HEALTHCARE QUALITY MANAGEMENT IN DEVELOPING REGIONS 34

4.4 OPPORTUNITIES 35

4.4.1 INCREASING PRODUCT LAUNCHES AND APPROVALS 35

4.4.2 ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE QUALITY MANAGEMENT 35

5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL 36

5.1.1 BARGAINING POWER OF SUPPLIERS 36

5.1.2 BARGAINING POWER OF BUYERS 37

5.1.3 THREAT OF NEW ENTRANTS 37

5.1.4 THREAT OF SUBSTITUTES 37

5.1.5 INTENSITY OF RIVALRY 37

5.2 VALUE CHAIN ANALYSIS 38

5.2.1 INPUTS 39

5.2.2 SOFTWARE DEVELOPMENT PROCESS 39

5.2.3 OUTPUT 39

5.2.4 MARKETING AND DISTRIBUTION 39

5.2.5 POST-SELLING SERVICES 39

6 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY SOFTWARE TYPE
6.1 OVERVIEW 40

6.2 BUSINESS INTELLIGENCE AND ANALYTICS SOLUTIONS 42

6.3 PHYSICIAN QUALITY REPORTING SOLUTIONS 43

6.4 CLINICAL RISK MANAGEMENT SOLUTIONS 44

6.5 PROVIDER PERFORMANCE IMPROVEMENT SOLUTIONS 45

6.6 OTHERS 45

7 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY MODE OF DEPLOYMENT
7.1 OVERVIEW 46

7.2 WEB/CLOUD-BASED 47

7.3 ON-PREMISE 48

8 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY APPLICATION
8.1 OVERVIEW 49

8.2 DATA MANAGEMENT 50

8.3 RISK MANAGEMENT 52

9 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY END USER
9.1 OVERVIEW 53

9.2 HOSPITALS 54

9.3 AMBULATORY CARE CENTERS 55

9.4 PAYERS 56

9.5 OTHERS 56

10 GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET, BY REGION
10.1 OVERVIEW 57

10.2 AMERICAS 59

10.2.1 NORTH AMERICA 63

10.2.2 LATIN AMERICA 71

10.3 EUROPE 74

10.3.1 WESTERN EUROPE 77

10.3.2 EASTERN EUROPE 96

10.4 ASIA-PACIFIC 99

10.4.1 JAPAN 103

10.4.2 CHINA 105

10.4.3 INDIA 108

10.4.4 AUSTRALIA 110

10.4.5 SOUTH KOREA 113

10.4.6 REST OF ASIA-PACIFIC 115

10.5 MIDDLE EAST & AFRICA 118

10.5.1 MIDDLE EAST 121

10.5.2 AFRICA 124

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 127

11.2 COMPETITIVE BENCHMARKING 128

11.3 COMPETITOR DASHBOARD 129

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL HEALTHCARE QUALITY MANAGEMENT MARKET 130

11.5 KEY DEVELOPMENT ANALYSIS 130

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 131

11.6.1 ACQUISITION ACTIVITIES 131

11.6.2 NEW PRODUCT/SERVICE LAUNCH 131

11.6.3 COLLABORATION 132

11.6.4 PARTNERSHIP 132

11.6.5 AGREEMENT 132

12 COMPANY PROFILE
12.1 CERNER CORPORATION 133

12.1.1 COMPANY OVERVIEW 133

12.1.2 FINANCIAL OVERVIEW 134

12.1.3 PRODUCTS/SERVICES OFFERED 135

12.1.4 KEY DEVELOPMENTS 135

12.1.5 SWOT ANALYSIS 136

12.1.6 KEY STRATEGIES 136

12.2 CITIUSTECH INC 137

12.2.1 COMPANY OVERVIEW 137

12.2.2 FINANCIAL OVERVIEW 137

12.2.3 PRODUCTS/SERVICES OFFERED 137

12.2.4 KEY DEVELOPMENTS 137

12.2.5 SWOT ANALYSIS 138

12.2.6 KEY STRATEGIES 138

12.3 DOLBEY SYSTEMS 139

12.3.1 COMPANY OVERVIEW 139

12.3.2 FINANCIAL OVERVIEW 139

12.3.3 PRODUCTS/SERVICES OFFERED 139

12.3.4 KEY DEVELOPMENTS 140

12.3.5 SWOT ANALYSIS 140

12.3.6 KEY STRATEGIES 141

12.4 ENLI HEALTH INTELLIGENCE 142

12.4.1 COMPANY OVERVIEW 142

12.4.2 FINANCIAL OVERVIEW 142

12.4.3 PRODUCTS/SERVICES OFFERED 142

12.4.4 KEY DEVELOPMENTS 142

12.4.5 SWOT ANALYSIS 143

12.4.6 KEY STRATEGIES 143

12.5 MCKESSON CORPORATION 144

12.5.1 COMPANY OVERVIEW 144

12.5.2 FINANCIAL OVERVIEW 145

12.5.3 PRODUCTS/SERVICES OFFERED 145

12.5.4 KEY DEVELOPMENTS 146

12.5.5 SWOT ANALYSIS 147

12.5.6 KEY STRATEGIES 147

12.6 MEDISOLV INC 148

12.6.1 COMPANY OVERVIEW 148

12.6.2 FINANCIAL OVERVIEW 148

12.6.3 PRODUCTS/SERVICES OFFERED 148

12.6.4 KEY DEVELOPMENTS 148

12.6.5 SWOT ANALYSIS 149

12.6.6 KEY STRATEGIES 149

12.7 NUANCE COMMUNICATIONS 150

12.7.1 COMPANY OVERVIEW 150

12.7.2 FINANCIAL OVERVIEW 150

12.7.3 PRODUCTS/SERVICES OFFERED 151

12.7.4 KEY DEVELOPMENTS 151

12.7.5 SWOT ANALYSIS 152

12.7.6 KEY STRATEGIES 152

12.8 PREMIER, INC 153

12.8.1 COMPANY OVERVIEW 153

12.8.2 FINANCIAL OVERVIEW 153

12.8.3 PRODUCTS/SERVICES OFFERED 154

12.8.4 KEY DEVELOPMENTS 154

12.8.5 SWOT ANALYSIS 155

12.8.6 KEY STRATEGIES 155

12.9 QUANTROS INC 156

12.9.1 COMPANY OVERVIEW 156

12.9.2 FINANCIAL OVERVIEW 156

12.9.3 PRODUCTS/SERVICES OFFERED 156

12.9.4 KEY DEVELOPMENTS 156

12.9.5 SWOT ANALYSIS 157

12.9.6 KEY STRATEGIES 157

12.10 TRUVEN HEALTH ANALYTICS 158

12.10.1 COMPANY OVERVIEW 158

12.10.2 FINANCIAL OVERVIEW 158

12.10.3 PRODUCTS/SERVICES OFFERED 158

12.10.4 KEY DEVELOPMENTS 158

12.10.5 SWOT ANALYSIS 159

12.10.6 KEY STRATEGIES 159

12.11 COTIVITI HOLDINGS, INC 160

12.11.1 COMPANY OVERVIEW 160

12.11.2 FINANCIAL OVERVIEW 161

12.11.3 PRODUCTS/SERVICES OFFERED 161

12.11.4 KEY DEVELOPMENTS 162

12.11.5 SWOT ANALYSIS 162

12.11.6 KEY STRATEGIES 162

13 APPENDIX
13.1 REFERENCES 163

13.2 RELATED REPORTS 163